Literature DB >> 18802401

Dissecting the role of the 3-phosphoinositide-dependent protein kinase-1 (PDK1) signalling pathways.

Jose R Bayascas1.   

Abstract

The 3-phosphoinositide-dependent protein kinase-1 (PDK1) mediates the cellular effect of insulin and growth factors by activating a group of kinases including PKB/Akt, S6K, RSK, SGK and PKC isoforms. PDK1 possesses two regulatory domains namely a Pleckstrin Homology (PH) domain that binds to the phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P(3)] second messenger, and a substrate binding site termed the PIF-pocket. Employing a combination of biochemical, structural and mouse knock-in approaches we have been able to define the roles that the regulatory domains on PDK1 play. We have established that binding of PDK1 to PtdIns(3,4,5)P(3) is essential for efficient activation of PKB isoforms as well as for maintaining normal cell size and insulin sensitivity. In contrast, the PIF-substrate binding pocket of PDK1 is not required for PKB activation, but is necessary for PDK1 to activate all of its other substrates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802401     DOI: 10.4161/cc.7.19.6810

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  46 in total

1.  Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Jennifer S Herrick; Roger K Wolff
Journal:  Mutat Res       Date:  2010-10-28       Impact factor: 2.433

2.  Saccharomyces cerivisiae as a model system for kidney disease: what can yeast tell us about renal function?

Authors:  Alexander R Kolb; Teresa M Buck; Jeffrey L Brodsky
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-13

3.  Influence of CHIEF pathway genes on gene expression: a pathway approach to functionality.

Authors:  Martha L Slattery; Abbie Lundgreen; Lila E Mullany; Rosalind B Penney; Roger K Wolff
Journal:  Int J Mol Epidemiol Genet       Date:  2014-05-29

4.  Early gene expression changes in the retinal ganglion cell layer of a rat glaucoma model.

Authors:  Ying Guo; Elaine C Johnson; William O Cepurna; Jennifer A Dyck; Tom Doser; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-18       Impact factor: 4.799

5.  Assessment of PI3K/AKT/PTEN signaling pathway activity in colorectal cancer using quantum dot-conjugated antibodies.

Authors:  Dariusz Waniczek; Mirosław Śnietura; Zbigniew Lorenc; Ewa Nowakowska-Zajdel; Małgorzata Muc-Wierzgoń
Journal:  Oncol Lett       Date:  2017-11-10       Impact factor: 2.967

6.  Neuroprotection of Sevoflurane Against Ischemia/Reperfusion-Induced Brain Injury Through Inhibiting JNK3/Caspase-3 by Enhancing Akt Signaling Pathway.

Authors:  Xiang-Ru Wen; Yan-Yan Fu; Hong-Zhi Liu; Jian Wu; Xiao-Ping Shao; Xun-Bao Zhang; Man Tang; Yue Shi; Kai Ma; Fang Zhang; Yi-Wen Wang; Hui Tang; Dong Han; Pu Zhang; Shu-Ling Wang; Zhou Xu; Yuan-Jian Song
Journal:  Mol Neurobiol       Date:  2015-02-17       Impact factor: 5.590

7.  Interaction of PDK1 with phosphoinositides is essential for neuronal differentiation but dispensable for neuronal survival.

Authors:  Tinatin Zurashvili; Lluís Cordón-Barris; Gerard Ruiz-Babot; Xiangyu Zhou; Jose M Lizcano; Nestor Gómez; Lydia Giménez-Llort; Jose R Bayascas
Journal:  Mol Cell Biol       Date:  2012-12-28       Impact factor: 4.272

8.  Fine-tuning the intensity of the PKB/Akt signal enables diverse physiological responses.

Authors:  Xiangyu Zhou; Lluis Cordon-Barris; Tinatin Zurashvili; Jose Ramon Bayascas
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 9.  Regulation of Akt signaling activation by ubiquitination.

Authors:  Wei-Lei Yang; Ching-Yuan Wu; Juan Wu; Hui-Kuan Lin
Journal:  Cell Cycle       Date:  2010-02-01       Impact factor: 4.534

10.  3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.

Authors:  Matthew Maurer; Tao Su; Lao H Saal; Susan Koujak; Benjamin D Hopkins; Christina R Barkley; Jiaping Wu; Subhadra Nandula; Bhaskar Dutta; Yuli Xie; Y Rebecca Chin; Da-In Kim; Jennifer S Ferris; Sofia K Gruvberger-Saal; Mervi Laakso; Xiaomei Wang; Lorenzo Memeo; Albert Rojtman; Tulio Matos; Jennifer S Yu; Carlos Cordon-Cardo; Jorma Isola; Mary Beth Terry; Alex Toker; Gordon B Mills; Jean J Zhao; Vundavalli V V S Murty; Hanina Hibshoosh; Ramon Parsons
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.